Patheon's webinar which took place on 28 June, is now available on demand
Formulation problems are arising with greater frequency, delaying development and burdening developers with unanticipated and heavy costs.
Identifying the critical attributes of the active pharmaceutical ingredient (API) and having a full understanding of the impact of these on the drug product manufacturing and scale-up is the key to anticipate problems and address them early.
Adapting the API manufacturing process and an early systematic characterisation could prepare the drug developers to solve problems earlier in the programme.
Led by Patheon's Anil Kane, Michael P. Cruskie, Jr, and Stephen Closs, the webinar addressed the following:
Register for access here.